DDInter657 DDInter832
A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Epoprostenol {u} (Compound) resembles {v} (Compound) Dinoprost Tromethamine
Epoprostenol {u} (Compound) resembles {v} (Compound) Treprostinil
Epoprostenol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alprostadil
Epoprostenol {u} (Compound) binds {v} (Gene) P2RY12
Epoprostenol {u} (Compound) palliates {v} (Disease) systemic scleroderma
Epoprostenol {u} (Compound) is included by {v} (Pharmacologic Class) Vasodilation
Epoprostenol {u} (Compound) causes {v} (Side Effect) Hypoaesthesia
Epoprostenol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Capsicum
Epoprostenol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Digoxin
Epoprostenol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Plicamycin
Epoprostenol (Compound) resembles Dinoprost Tromethamine (Compound)
Epoprostenol (Compound) resembles Treprostinil (Compound)
Epoprostenol may cause a moderate interaction that could exacerbate diseases when taken with Alprostadil
Epoprostenol (Compound) binds P2RY12 (Gene)
Epoprostenol (Compound) palliates systemic scleroderma (Disease)
Epoprostenol (Compound) is included by Vasodilation (Pharmacologic Class)
Epoprostenol (Compound) causes Hypoaesthesia (Side Effect)
Epoprostenol may cause a minor interaction that can limit clinical effects when taken with Capsicum
Epoprostenol may cause a minor interaction that can limit clinical effects when taken with Digoxin
Epoprostenol may cause a moderate interaction that could exacerbate diseases when taken with Plicamycin